Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSC for Early Stage Osteonecrosis of Femoral Head
NCT03180463Phase 2Suspended
- Sponsor
- Sclnow Biotechnology Co., Ltd.
- Start
- Dec 2026
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in osteonecrosis of the femoral head (ONFH), sponsored by Sclnow Biotechnology Co., Ltd.. Planned start Dec 2026; status: suspended.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
osteonecrosis of the femoral head (ONFH)
Beyond the preview
Go deeper on NCT03180463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180463.